Payer coverage policies for multigene tests
- 1 July 2017
- journal article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 35 (7), 614-617
- https://doi.org/10.1038/nbt.3912
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screeningGenetics in Medicine, 2017
- Developing context-specific next-generation sequencing policyNature Biotechnology, 2016
- Availability and payer coverage of BRCA1/2 tests and gene panelsNature Biotechnology, 2015
- Challenges of Coverage Policy Development for Next-Generation Tumor Sequencing Panels: Experts and Payers Weigh InJournal of the National Comprehensive Cancer Network, 2015
- Overcoming the reimbursement barriers for clinical sequencing.JAMA, 2014
- Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payersPersonalized Medicine, 2013
- Insurance Coverage Policies for Personalized MedicineJournal of Personalized Medicine, 2012
- Health Technology Assessment and Private Payers' Coverage of Personalized MedicineJournal of Oncology Practice, 2011
- Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene AssayJournal of Oncology Practice, 2010
- Closing the Evidence Gap in the Use of Emerging Testing Technologies in Clinical PracticeJAMA, 2008